酵素の世界市場レポート 2025

酵素の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR14.0％で258億8,000万米ドルに成長します。予測期間の成長は、市場の需要ダイナミクス、持続可能な実践への注目、健康と栄養の動向、バイオ燃料と再生可能エネルギー、新興アプリケーションに起因しています。予測期間の主な動向には、バイオテクノロジーの進歩、持続可能性の要求、飲食品業界の需要、産業用途の拡大、天然製品に対する消費者の嗜好などが含まれます。

酵素市場は、消化器系疾患の有病率の増加によって成長が見込まれます。消化器系に影響を及ぼすこれらの疾患には、胃食道逆流症（GERD）、がん、過敏性腸症候群（IBS）、乳糖不耐症、食道裂孔ヘルニア、胆石などの疾患が含まれます。消化器系の酵素は、食物を吸収可能な分子に分解するという重要な役割を担っています。2022年10月現在、米国国立生物工学情報センター（NCBI）によると、米国における過敏性腸症候群（IBS）の有病率は10％～15％であり、プライマリ・ケア診療においてIBS関連の懸念のために医療を求める患者は12％近くにのぼる。このような消化器系疾患の増加は、酵素市場の成長に寄与しています。

酵素市場は、化学療法に薬物代謝酵素（DMEs）を使用する必要があるがんの有病率の増加によって活性化されると予想されます。これらの酵素は体内で活性化し、がん細胞を破壊し、腫瘍を破壊します。がん患者の腫瘍組織や代謝器官における薬物代謝酵素（DMEs）の発現と機能性は、抗がん剤や化学療法に対する反応が低い患者にとって極めて重要です。米国がん協会によるCancer Facts and Figures 2022報告書によると、2022年に米国で新たに発生するがん患者数は推定190万人で、2020年に報告された180万人から増加しています。一方、2022年の推定がん死亡者数は、2021年の60万8,570人に対し60万9,360人と、2021年よりわずかに増加しています。酵素治療で治療可能ながんの有病率の上昇は、酵素市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界酵素 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の酵素市場：成長率分析
• 世界の酵素市場の実績：規模と成長, 2019-2024
• 世界の酵素市場の予測：規模と成長, 2024-2029, 2034F
• 世界酵素総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の酵素市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アスパルギナーゼ
• リパーゼ
• プロテアーゼ
• ナットウキナーゼ
• キチナーゼ
• セラチオペプチダーゼ
• コラーゲナーゼ
• リガーゼ
• その他の製品
• 世界の酵素市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 白血病
• 胃の病気
• 抗腫瘍
• 皮膚潰瘍
• ゴーシェ病
• ファブリー病
• その他の用途
• 世界の酵素市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品メーカー
• 病院
• 個人クリニック
• 調査室
• 世界の酵素市場アスパラギナーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• L-アスパラギナーゼ
• エルウィニアアスパラギナーゼ
• ペグ化アスパラギナーゼ
• 世界の酵素市場リパーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 胃リパーゼ
• 膵リパーゼ
• 真菌リパーゼ
• 細菌リパーゼ
• 世界の酵素市場、プロテアーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• セリンプロテアーゼ
• システインプロテアーゼ
• アスパラギン酸プロテアーゼ
• メタロプロテアーゼ
• 世界の酵素市場ナットウキナーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ナットウキナーゼパウダー
• ナットウキナーゼカプセル
• 世界の酵素市場キチナーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 植物キチナーゼ
• 微生物キチナーゼ
• 世界の酵素市場セラチオペプチダーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• セラチオペプチダーゼ錠
• セラチオペプチダーゼカプセル
• 世界の酵素市場コラーゲナーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• I型コラーゲナーゼ
• II型コラーゲナーゼ
• III型コラーゲナーゼ
• 世界の酵素市場、リガーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNAリガーゼ
• RNAリガーゼ
• 世界の酵素市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アミラーゼ
• セルラーゼ
• ベータグルカナーゼ
• その他の専門酵素

第7章 地域別・国別分析

• 世界の酵素市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の酵素市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 酵素市場：競合情勢
• 酵素市場：企業プロファイル
  • Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis
  • DuPont Industrial Biosciences Overview, Products and Services, Strategy and Financial Analysis
  • BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke DSM N.V. Overview, Products and Services, Strategy and Financial Analysis
  • Chr. Hansen Holding A/S Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Roche Holding AG
• Advanced Enzyme Technologies Ltd.
• AB Enzymes GmbH
• Codexis Inc.
• Dyadic International Inc.
• Amano Enzyme Inc.
• Adisseo France SAS
• Biocatalysts Ltd.
• Amano Enzyme Inc.（duplicate）
• Enzyme Development Corporation
• Creative Enzymes
• Hayashibara Co. Ltd.
• Thermo Fisher Scientific Inc.
• Associated British Foods Plc
• Lonza Group AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 酵素市場2029：新たな機会を提供する国
• 酵素市場2029：新たな機会を提供するセグメント
• 酵素市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

An enzyme is a protein that typically functions as a biological catalyst. It speeds up specific chemical reactions within cells. Enzymes are substances that act as catalysts in living organisms, regulating the rate of chemical processes without being altered themselves.

Various enzyme product types include asparaginase, lipase, protease, nattokinase, chitinase, serratiopeptidase, collagenase, ligase, and others. Protease, for instance, catalyzes proteolysis, breaking down proteins into smaller polypeptides or individual amino acids while facilitating the creation of new protein products. These enzymes find application in treating conditions such as leukemia, stomach disorders, antitumor therapies, skin ulcers, Gaucher disease, Fabry disease, among others. They are utilized by drug manufacturers, hospitals, private clinics, and research laboratories.

The enzymes market research report is one of a series of new reports from The Business Research Company that provides enzymes market statistics, including enzymes industry global market size, regional shares, competitors with an enzymes market share, detailed enzymes market segments, market trends, and opportunities, and any further data you may need to thrive in the enzymes industry. This enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The enzymes market size has grown rapidly in recent years. It will grow from $13.38 billion in 2024 to $15.33 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to globalization and market expansion, research and development investments, consumer awareness and demand, bioprocessing technology improvements, waste reduction and recycling.

The enzymes market size is expected to see rapid growth in the next few years. It will grow to $25.88 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to market demand dynamics, focus on sustainable practices, health and nutrition trends, biofuel and renewable energy, emerging applications. Major trends in the forecast period include biotechnology advancements, sustainability demands, food and beverage industry demand, industrial applications expansion, consumer preference for natural products.

The enzyme market is anticipated to experience growth driven by an increase in the prevalence of digestive disorders. These disorders, impacting the digestive system, encompass conditions such as gastroesophageal reflux disease (GERD), cancer, irritable bowel syndrome (IBS), lactose intolerance, hiatal hernia, and gallstones. Digestive enzymes play a crucial role in breaking down food into absorbable molecules. As of October 2022, the National Center for Biotechnology Information (NCBI) reports that the prevalence of irritable bowel syndrome (IBS) in the United States ranges between 10% and 15%, with nearly 12% of patients seeking medical care for IBS-related concerns in primary care practices. This rise in digestive disorders contributes to the growth of the enzyme market.

The enzyme market is expected to be fueled by the increasing prevalence of cancer, necessitating the use of drug-metabolizing enzymes (DMEs) for chemotherapy. These enzymes activate within the body to destroy cancer cells and break down tumors. The expression and functionality of drug-metabolizing enzymes (DMEs) in the tumor tissues and metabolic organs of cancer patients are crucial for those with a low response to anticancer drugs and chemotherapy. The Cancer Facts and Figures 2022 report by the American Cancer Society indicates an estimated 1.9 million new cancer cases in the United States in 2022, reflecting an increase from the 1.8 million reported in 2020. While the estimated number of cancer deaths in 2022 is slightly higher than in 2021, with 609,360 projected deaths compared to 608,570 in 2021. The rising prevalence of cancer treatable with therapeutic enzymes is anticipated to propel the growth of the enzyme market.

Leading companies in the enzyme market are focusing on innovation by developing advanced products such as Lamzede, catering to the needs of patients. Lamzede (velmanase alfa) is a pharmaceutical product designed for the treatment of alpha-mannosidosis, a rare genetic disorder characterized by insufficient activity of the lysosomal alpha-galactosidase-A enzyme. In a noteworthy development in May 2023, Chiesi Global Rare Diseases, a pharmaceutical manufacturing company based in the United States, obtained FDA approval for Lamzede (velmanase alfa). This approval pertains to the treatment of non-neurological symptoms in patients with mild-to-moderate alpha-mannosidosis. Lamzede represents a recombinant form of human alpha-mannosidase, developed using recombinant DNA technology in mammalian Chinese hamster ovary (CHO) cells. It stands out as the first enzyme replacement therapy sanctioned in the U.S. for addressing the non-central nervous system manifestations of alpha-mannosidosis.

A notable trend gaining prominence in the enzymes market is the exploration of novel approaches for cancer treatment utilizing enzymes. Substantial investments in research by major universities and companies aim to advance enzyme therapies for combating cancer. In another significant development in May 2023, Chiesi Global Rare Diseases secured FDA approval for ELFABRIO (pegunigalsidase alfa-iwxj), designed to address Fabry disease. This rare genetic disorder is characterized by insufficient activity of the lysosomal a-galactosidase-A enzyme, leading to the progressive accumulation of globotriaosylceramide (Gb3) in blood vessel walls throughout the body. ELFABRIO (pegunigalsidase alfa-iwxj) stands out as a PEGylated enzyme replacement therapy (ERT).

In February 2023, AstraZeneca, a U.S.-based pharmaceutical company, completed the acquisition of CinCor Pharma Inc. for $1.3 billion. This strategic move is set to strengthen AstraZeneca's cardiorenal pipeline through the incorporation of CinCor's candidate drug, baxdrostat (CIN-107). Baxdrostat is an aldosterone synthase inhibitor (ASI) designed for lowering blood pressure in individuals with treatment-resistant hypertension. CinCor Pharma Inc., the acquired biotechnology company, is based in the United States and is focused on the development of enzyme-based therapeutics.

Major companies operating in the enzymes market include Novozymes A/S, DuPont Industrial Biosciences, BASF SE, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Amano Enzyme Inc., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc., Epygen Biotech, DSM Nutritional Products AG, Soufflet Biotechnologies SAS, Beijing Leili Marine Bioindustry Inc., Jiangsu Boli Bioproducts Co. Ltd.

North America was the largest region in the enzymes market in 2024. The regions covered in the enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The enzyme market consists of sales of oxidoreductases, transferases, and hydrolases. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzymes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enzymes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Asparaginase; Lipase; Protease; Nattokinase; Chitinase; Serratiopeptidase; Collagenase; Ligase; Other Products
• 2) By Application: Leukemia; Stomach Disorders; Antitumor; Skin Ulcers; Gaucher Disease; Fabry Disease; Other Applications
• 3) By End User: Drug Manufacturers; Hospitals; Private Clinics; Research Laboratories
• Subsegments:
• 1) By Asparaginase: L-asparaginase; Erwinia Asparaginase; Pegylated Asparaginase
• 2) By Lipase: Gastric Lipase; Pancreatic Lipase; Fungal Lipase; Bacterial Lipase
• 3) By Protease: Serine Proteases; Cysteine Proteases; Aspartic Proteases; Metalloproteases
• 4) By Nattokinase: Nattokinase Powder; Nattokinase Capsules
• 5) By Chitinase: Plant Chitinase; Microbial Chitinase
• 6) By Serratiopeptidase: Serratiopeptidase Tablets; Serratiopeptidase Capsules
• 7) By Collagenase: Type I Collagenase; Type II Collagenase; Type III Collagenase
• 8) By Ligase: DNA Ligase; RNA Ligase
• 9) By Other Products: Amylase; Cellulase; Beta-Glucanase; Other Specialty Enzymes
• Companies Mentioned: Novozymes A/S; DuPont Industrial Biosciences; BASF SE; Koninklijke DSM N.V.; Chr. Hansen Holding A/S
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enzymes Market Characteristics

3. Enzymes Market Trends And Strategies

4. Enzymes Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Enzymes Growth Analysis And Strategic Analysis Framework

• 5.1. Global Enzymes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Enzymes Market Growth Rate Analysis
• 5.4. Global Enzymes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Enzymes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Enzymes Total Addressable Market (TAM)

6. Enzymes Market Segmentation

• 6.1. Global Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Asparginase
• Lipase
• Protease
• Nattokinase
• Chitinase
• Serratiopeptidase
• Collagenase
• Ligase
• Other Products
• 6.2. Global Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukemia
• Stomach Disorders
• Antitumor
• Skin Ulcers
• Gaucher Disease
• Fabry Disease
• Other Applications
• 6.3. Global Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Manufacturers
• Hospitals
• Private Clinics
• Research Laboratories
• 6.4. Global Enzymes Market, Sub-Segmentation Of Asparaginase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• L-asparaginase
• Erwinia Asparaginase
• Pegylated Asparaginase
• 6.5. Global Enzymes Market, Sub-Segmentation Of Lipase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gastric Lipase
• Pancreatic Lipase
• Fungal Lipase
• Bacterial Lipase
• 6.6. Global Enzymes Market, Sub-Segmentation Of Protease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serine Proteases
• Cysteine Proteases
• Aspartic Proteases
• Metalloproteases
• 6.7. Global Enzymes Market, Sub-Segmentation Of Nattokinase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nattokinase Powder
• Nattokinase Capsules
• 6.8. Global Enzymes Market, Sub-Segmentation Of Chitinase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plant Chitinase
• Microbial Chitinase
• 6.9. Global Enzymes Market, Sub-Segmentation Of Serratiopeptidase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serratiopeptidase Tablets
• Serratiopeptidase Capsules
• 6.10. Global Enzymes Market, Sub-Segmentation Of Collagenase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type I Collagenase
• Type II Collagenase
• Type III Collagenase
• 6.11. Global Enzymes Market, Sub-Segmentation Of Ligase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Ligase
• RNA Ligase
• 6.12. Global Enzymes Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amylase
• Cellulase
• Beta-Glucanase
• Other Specialty Enzymes

7. Enzymes Market Regional And Country Analysis

• 7.1. Global Enzymes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Enzymes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Enzymes Market

• 8.1. Asia-Pacific Enzymes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Enzymes Market

• 9.1. China Enzymes Market Overview
• 9.2. China Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Enzymes Market

• 10.1. India Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Enzymes Market

• 11.1. Japan Enzymes Market Overview
• 11.2. Japan Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Enzymes Market

• 12.1. Australia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Enzymes Market

• 13.1. Indonesia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Enzymes Market

• 14.1. South Korea Enzymes Market Overview
• 14.2. South Korea Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Enzymes Market

• 15.1. Western Europe Enzymes Market Overview
• 15.2. Western Europe Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Enzymes Market

• 16.1. UK Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Enzymes Market

• 17.1. Germany Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Enzymes Market

• 18.1. France Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Enzymes Market

• 19.1. Italy Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Enzymes Market

• 20.1. Spain Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Enzymes Market

• 21.1. Eastern Europe Enzymes Market Overview
• 21.2. Eastern Europe Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Enzymes Market

• 22.1. Russia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Enzymes Market

• 23.1. North America Enzymes Market Overview
• 23.2. North America Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Enzymes Market

• 24.1. USA Enzymes Market Overview
• 24.2. USA Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Enzymes Market

• 25.1. Canada Enzymes Market Overview
• 25.2. Canada Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Enzymes Market

• 26.1. South America Enzymes Market Overview
• 26.2. South America Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Enzymes Market

• 27.1. Brazil Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Enzymes Market

• 28.1. Middle East Enzymes Market Overview
• 28.2. Middle East Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Enzymes Market

• 29.1. Africa Enzymes Market Overview
• 29.2. Africa Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Enzymes Market Competitive Landscape And Company Profiles

• 30.1. Enzymes Market Competitive Landscape
• 30.2. Enzymes Market Company Profiles
  • 30.2.1. Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. DuPont Industrial Biosciences Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke DSM N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Chr. Hansen Holding A/S Overview, Products and Services, Strategy and Financial Analysis

31. Enzymes Market Other Major And Innovative Companies

• 31.1. Roche Holding AG
• 31.2. Advanced Enzyme Technologies Ltd.
• 31.3. AB Enzymes GmbH
• 31.4. Codexis Inc.
• 31.5. Dyadic International Inc.
• 31.6. Amano Enzyme Inc.
• 31.7. Adisseo France SAS
• 31.8. Biocatalysts Ltd.
• 31.9. Amano Enzyme Inc. (duplicate)
• 31.10. Enzyme Development Corporation
• 31.11. Creative Enzymes
• 31.12. Hayashibara Co. Ltd.
• 31.13. Thermo Fisher Scientific Inc.
• 31.14. Associated British Foods Plc
• 31.15. Lonza Group AG

32. Global Enzymes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Enzymes Market

34. Recent Developments In The Enzymes Market

35. Enzymes Market High Potential Countries, Segments and Strategies

• 35.1 Enzymes Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Enzymes Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Enzymes Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer